Clinitech Lab

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0QMR01015
  • NSEID:
  • BSEID: 544220
INR
32.72
-1.43 (-4.19%)
BSENSE

Nov 20

BSE+NSE Vol: 13200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039331,
    "name": "Clinitech Lab",
    "stock_name": "Clinitech Lab",
    "full_name": "Clinitech Laboratory Ltd",
    "name_url": "stocks-analysis/clinitech-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.72",
    "chg": -1.43,
    "chgp": "-4.19%",
    "dir": -1,
    "prev_price": "34.15",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544220,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0QMR01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 13200,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/clinitech-lab-10039331-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039331",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/clinitech-laboratory-10039331"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "20-Nov-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bylan - Niraj Infra Projects Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30 2026",
      "datetime": "13-Nov-2026",
      "details": "Outcome of Board Meeting held on Friday November 13 2026 at 12.00 Noon through video conferencing for approval of unaudited Standalone & Consolidated Financial Results for the half year ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations 2015",
      "datetime": "13-Nov-2026",
      "details": "Declaration of Statement of deviation or variation under Regulation 32 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

20-Nov-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bylan - Niraj Infra Projects Pvt Ltd

Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30 2026

13-Nov-2026 | Source : BSE

Outcome of Board Meeting held on Friday November 13 2026 at 12.00 Noon through video conferencing for approval of unaudited Standalone & Consolidated Financial Results for the half year ended September 30 2026

Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations 2015

13-Nov-2026 | Source : BSE

Declaration of Statement of deviation or variation under Regulation 32 of SEBI (LODR) Regulations 2015

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available